Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.56106 | 23 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.54172 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.54303 | 23 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.47159 | 22 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.49353 | 23 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.5753 | 22 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.54317 | 22 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.52081 | 23 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.51812 | 23 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.53893 | 24 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.53046 | 23 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.51694 | 23 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.53759 | 23 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.53589 | 23 |